Amine-reactive OVA Multimers for Auto-vaccination Against Cytokines and Other Mediators: Perspectives Illustrated for GCP-2 in L. Major Infection
Overview
Authors
Affiliations
Anticytokine auto-vaccination is a powerful tool for the study of cytokine functions in vivo but has remained rather esoteric as a result of numerous technical difficulties. We here describe a two-step procedure based on the use of OVA multimers purified by size exclusion chromatography after incubation with glutaraldehyde at pH 6. When such polymers are incubated with a target protein at pH 8.5 to deprotonate reactive amines, complexes are formed that confer immunogenicity to self-antigens. The chemokine GCP-2/CXCL6, the cytokines GM-CSF, IL-17F, IL-17E/IL-25, IL-27, and TGF-β1, and the MMP-9/gelatinase B are discussed as examples. mAb, derived from such immunized mice, have obvious advantages for in vivo studies of the target proteins. Using a mAb against GCP-2, obtained by the method described here, we provide the first demonstration of the major role played by this chemokine in rapid neutrophil mobilization after Leishmania major infection. Pre-activated OVA multimers reactive with amine residues thus provide an efficient carrier for auto-vaccination against 9-90 kDa autologous proteins.
Ndoricyimpaye E, Van Snick J, Niyoyita J, Kanimba P, Mbonimpa J, Rutayisire R Int J Mol Sci. 2022; 23(20).
PMID: 36293524 PMC: 9603849. DOI: 10.3390/ijms232012665.
Gong H, Ma S, Chen J, Yang B, Liu S, Liu X Signal Transduct Target Ther. 2022; 7(1):319.
PMID: 36109504 PMC: 9477797. DOI: 10.1038/s41392-022-01147-z.
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.
Gupta A, Budhu S, Fitzgerald K, Giese R, Michel A, Holland A Commun Biol. 2021; 4(1):1296.
PMID: 34789823 PMC: 8599839. DOI: 10.1038/s42003-021-02773-z.
The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by Infection.
Passelli K, Billion O, Tacchini-Cottier F Front Immunol. 2021; 12:649348.
PMID: 33732265 PMC: 7957080. DOI: 10.3389/fimmu.2021.649348.
Cane S, Van Snick J, Uyttenhove C, Pilotte L, Van den Eynde B J Immunother Cancer. 2021; 9(2).
PMID: 33637600 PMC: 7919595. DOI: 10.1136/jitc-2020-001798.